Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 26, 2009
Human Molecular Genetics 2009 18(12):2177-2187; doi:10.1093/hmg/ddp150
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
18/12/2177    most recent
ddp150v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Li, C.
Right arrow Articles by Liu, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, C.
Right arrow Articles by Liu, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Correlation of expression and methylation of imprinted genes with pluripotency of parthenogenetic embryonic stem cells

Chao Li1,2, Zhisheng Chen1, Zhong Liu1, Junjiu Huang1,3, Wei Zhang1, Lingjun Zhou1, David L. Keefe3 and Lin Liu2,3,*

1 School of Life Science, Sun Yat-Sen University, Guangzhou 510275, China 2 Key Laboratory of Bioactive Materials of Ministry of Education, College of Life Sciences, New Biological Station C301, Nankai University, 94 Weijin Road, Tianjin 300071, China 3 Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa, FL 33612, USA

* To whom correspondence should be addressed. Tel: +86 2223500752; Fax: +86 2223500752; Email: liutelom{at}yahoo.com or liulin{at}nankai.edu.cn

Received December 22, 2008; Revised February 9, 2009; Accepted March 24, 2009

Mammalian parthenogenetic embryos (pE) are not viable due to placental deficiency, presumably resulting from lack of paternally expressed imprinted genes. Pluripotent parthenogenetic embryonic stem (pES) cells derived from pE could advance regenerative medicine by avoiding immuno-rejection and ethical roadblocks. We attempted to explore the epigenetic status of imprinted genes in the generation of pES cells from parthenogenetic blastocysts, and its relationship to pluripotency of pES cells. Pluripotency was evaluated for developmental and differentiation potential in vivo, based on contributions of pES cells to chimeras and development to day 9.5 of pES fetuses complemented by tetraploid embryos (TEC). Consistently, pE and fetuses failed to express paternally expressed imprinted genes, but pES cells expressed those genes in a pattern resembling that of fertilized embryos (fE) and fertilized embryonic stem (fES) cells derived from fE. Like fE and fES cells, but unlike pE or fetuses, pES cells and pES cell–fetuses complemented by TEC exhibited balanced methylation of Snrpn, Peg1 and U2af1-rs1. Coincidently, global methylation increased in pE but decreased in pES cells, further suggesting dramatic epigenetic reprogramming occurred during isolation and culture of pES cells. Moreover, we identified decreased methylation of Igf2r, Snrpn, and especially U2af1-rs1, in association with increased contributions of pES cells to chimeras. Our data show that in vitro culture changes epigenetic status of imprinted genes during isolation of pES cells from their progenitor embryos and that increased expression of U2af1-rs1 and Snrpn and decreased expression of Igf2r correlate with pluripotency of pES cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.